Company: TCRG
Filing Date: 2025-03-21
Form Type: 10-K
Source: 0001185185-25-000206
Chunk: 8

Company: Cannaisseur Group Inc.
Filing Date: 2025-03-21
Form: 10-K
Item: Item 1
Chunk 8
---
 to predict the likely outcome of this process FDA has initiated.

d.Hemp-derived
CBD products are subject to regulation on the state level.

Although
the AIA provided clarity regarding the status of hemp-derived CBD under the federal CSA, the AIA did not address the myriad state laws
and regulations governing such products. For example, hemp-derived CBD still meets the definition of a controlled substance under
certain laws.

Our
health and wellness products are regulated by the Food and Drug Administration (FDA)

We
are subject to the rules of the FDA under the Federal Food, Drug, and Cosmetic Act, which regulates the formulation, manufacturing, packaging,
labeling, and distribution of food, dietary supplements, drugs, cosmetic, medical devices, biologics, and tobacco products. The FDA regulates
the wellness industry by focusing on the safety, efficacy, and security of products like dietary supplements, food, beverages, drugs,
medical devices, and cosmetics, ensuring they are safe for consumers and accurately labeled, while also providing information to support
healthy choices.

The
Cannaisseur Group, Inc., is a Delaware corporation, and the operator of the website, https://thecannaisseurgroup.com/.

8

Item
1A. Risk Factors

An
investment in our common stock involves a high degree of risk. An investor should carefully consider the following risk factors and the
other information in this registration statement before investing in our common stock. Our business and results of operations could be
seriously harmed by any of the following risks.

A
pandemic, epidemic or outbreak of an infectious disease in the markets in which the Company operates or that otherwise impacts its facilities
and customers could adversely impact the Company’s business.

If
a pandemic, epidemic, or outbreak of an infectious disease including an outbreak of respiratory illness caused by a novel virus, or other
public health crisis, were to affect the Company’s markets or facilities, or its customers, the Company’s business could
be adversely affected. If such an infectious disease broke out at the Company’s office, facilities or work sites, its operations
may be affected significantly, its productivity may be affected, and the Company may incur increased costs. If the persons and entities
with which the Company contracts are affected by an outbreak of infectious disease, its live events may be delayed or cancelled, and
the Company may incur increased costs. If the Company’s employees or subcontractors with whom it works were affected by an outbreak
of infectious disease, the Company’s labor